Cancer research
Researchers from Shandong Provincial Hospital and Shandong First Med Univ have made a groundbreaking discovery in the field of gastric cancer treatment. By leveraging nanoparticle-based immunotherapy, they have successfully targeted the CXCL12-CXCR4 signaling pathway, reprogramming tumor-associated macrophages to enhance anti-tumor immunity. This novel approach has shown significant promise in suppressing
Cancer research
The Fred Hutchinson Cancer Research Center is leading the Vanguard Study, a national study aimed at evaluating the effectiveness and use of multi-cancer detection blood tests. This new type of blood test screens for several different cancers and has the potential to diagnose cancer earlier, when it may be easier
Cancer research
A new study from the Medical University of Warsaw suggests that ChatGPT, a large language model, can provide accurate and comprehensive information on cervical cancer screening. The research concluded that ChatGPT-generated information on the topic is clear, coherent, and appropriate for the target audience, confirming the model's potential
Cancer research
BriaCell Therapeutics Corp., a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, has announced the addition of Mayo Clinic to its ongoing pivotal Phase 3 clinical study in metastatic breast cancer. The study, which is evaluating BriaCell's lead clinical candidate, Bria-IMT(TM), plus immune checkpoint inhibitor
Cancer research
Sentara Health is partnering with a national network of researchers to study the effectiveness of Multi-Cancer Detection (MCD) tests in detecting various cancer types. The Vanguard Study, a part of the Cancer Screening Research Network (CSRN), aims to evaluate whether these blood tests can help identify cancers early when they
Cancer research
Research published in Scientific Reports has examined the effectiveness of early cancer screening programs in China, specifically targeting high-risk populations. A survey of 75,554 participants aged 40-74 in Nanchang, China, between 2018 and 2022 revealed an overall high-risk rate of 54.12%. The study found that lung cancer had
Cancer research
Researchers from the University of Tennessee, Knoxville, have made significant progress in using artificial intelligence and machine learning to provide treatment plans to breast cancer patients more quickly. By analyzing pathology reports and other clinical records, the team has developed a system that determines the extent of breast cancer in
Cancer research
Researchers at the Guangzhou University of Chinese Medicine have developed a machine learning-based model to predict breast cancer incidence risk by incorporating both personal clinical factors and peripheral blood biochemical biomarkers. The study aimed to enhance the understanding of breast cancer risk by identifying novel risk factors using machine learning
Cancer research
Researchers from the University of Orebro conducted a study to evaluate the effectiveness of a nationwide screening program for colorectal cancer (CRC) in Sweden, particularly in the Region & Ouml;rebro County (RÖC). The study compared CRC screening colonoscopies with a standardized care course for CRC (SCC-CRC) colonoscopies among patients
Cancer research
Recent research published in Drug Design, Development and Therapy has investigated the effects of remimazolam on elderly patients undergoing laparoscopic colorectal surgery. The study, conducted by Zhenqi Liu and colleagues at the Department of Anesthesiology, found that medium and high doses of remimazolam can significantly reduce the incidence of perioperative
Cancer research
New research out of Taiwan has made significant strides in improving the detection accuracy of breast cancer through mammography. The study, led by researchers at National Tsing Hua University, employed deep learning-based computer-aided diagnosis systems to evaluate the effectiveness of transfer learning, image preprocessing techniques, and the latest You Only
Cancer research
New research from YuceBio Technology Co. Ltd. has shown promising results for the use of neoadjuvant immunochemotherapy in treating cervical cancer. The study, which was published in the journal Signal Transduction and Targeted Therapy, aimed to evaluate the efficacy and safety of combining the anti-programmed cell death protein 1 (PD-1)
